Both the Wnt/β-catenin pathway and the phosphatidylinositol-3-kinase/Akt/mechanistic target of rapamycin complex 1 (PI3K/Akt/mTOR) pathway are upregulated in many cancers. This evidence concerns the gene AKT1 and cancer.